entertainment -WSS

entertainment

author：explore 2025-09-29 20:52:53 - browse：5

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： First transplant of an entire human eye performed

WSS

Weight loss drugs should be covered by insurers, AMA says

Medical school prerequisites are outdated

White House drug czar issues call for 'recovery

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

FDA reorg will put new emphasis on investigations, sources say

hotspot

entertainment

focus

What does generative AI mean for health care? We asked experts

Cancer diagnosis changes perspective doctor, former hospital CEO

Supreme Court strikes down use of affirmative action

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Heart attack and stroke risk calculators need revising

EU moves toward latest gene techniques in food production to counter climate change, shortages

Peter Hotez and the public health issue of online harassment

What health policies could hitch a ride on a spending bill?

United colonoscopy coverage change 'may cost lives,' doctors say

NIH chief: government has fallen behind pharma on clinical trials

focus

Experimental asthma app from Apple and Anthem shows promise

FDA reorg will put new emphasis on investigations, sources say

Pentagon will tighten controls on classified information after Discord leak

A bus careens into a gulch in southern Mexico, leaving 27 people dead

Ohio still needs to do more to protect the right to abortion

Pope Francis asks Church to identify 21st

Wikipedia

knowledge

hotspot

hotspot